Literature DB >> 20026264

Postnatally induced inactivation of Osterix in osteoblasts results in the reduction of bone formation and maintenance.

Wook-Young Baek1, Benoit de Crombrugghe, Jung-Eun Kim.   

Abstract

Osterix (Osx) is a zinc-finger-containing transcription factor that is highly specific to osteoblasts in vivo. Because Osx homozygous null mutants die in the immediate perinatal period showing a complete absence of bone formation, it is impossible determine the role that Osx plays in bones that have already formed after birth. To determine whether Osx is essential for bone maintenance and homeostasis, we conditionally inactivated the Osx gene in adult bone using the Cre/loxP recombination system. In previous reports, 2.3-kb Col1a1-CreERT2 mice that expressed a Cre recombinase that is transiently inducible by 4-hydroxytamoxifen (4-OHT) were intercrossed with Rosa26R (R26R) reporter mice, which resulted in the production of Cre-expressing osteoblasts that were detected upon X-gal staining. In the present study, inducible Col1a1-CreERT2 transgenic mice and conditional Osx mice (Osx(flox/+)) were used to generate Osx(flox/-);Col1a1-CreERT2 mice. The Osx gene in Osx(flox/-);Col1a1-CreERT2 mice was inactivated in the osteoblasts of already formed bones by active Cre recombinase after the administration of 4-OHT. The bones from 4-OHT-treated Osx(flox/-);Col1a1-CreERT2 mice and oil-treated control mice were analyzed by radiography, histology, and histomorphometry. Even though no significant difference was observed in the radiographic images of the whole mouse skeletons, the mineralized trabecular bone volume and number in lumbar vertebrae were remarkably reduced in 4-OHT-treated Osx(flox/-);Col1a1-CreERT2 mice. In addition, the rate of bone formation and area of mineralized surface were also reduced in 4-OHT-treated Osx(flox/-);Col1a1-CreERT2 mice. Osx inactivation in already formed bones during the postnatal period caused a functional defect in osteoblasts that was followed by a reduction of bone formation, even though there were no apparent differences in osteoblast proliferation and osteoclast formation. Taken together, these results indicate that Osx is required to maintain osteoblast function following adult bone maintenance. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20026264      PMCID: PMC4012767          DOI: 10.1016/j.bone.2009.12.007

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  35 in total

Review 1.  Conditional gene knockout using cre recombinase.

Authors:  Y Le; B Sauer
Journal:  Methods Mol Biol       Date:  2000

2.  The right time and place for molecular scissors.

Authors:  L Hennighausen; P A Furth
Journal:  Nat Biotechnol       Date:  1999-11       Impact factor: 54.908

Review 3.  Role of Cbfa1 in osteoblast differentiation and function.

Authors:  G Karsenty
Journal:  Semin Cell Dev Biol       Date:  2000-10       Impact factor: 7.727

Review 4.  Control of osteoblast function and regulation of bone mass.

Authors:  Shun-ichi Harada; Gideon A Rodan
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

5.  Site- and time-specific gene targeting in the mouse.

Authors:  D Metzger; P Chambon
Journal:  Methods       Date:  2001-05       Impact factor: 3.608

6.  Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.

Authors:  A R Utomo; A Y Nikitin; W H Lee
Journal:  Nat Biotechnol       Date:  1999-11       Impact factor: 54.908

7.  The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.

Authors:  Kazuhisa Nakashima; Xin Zhou; Gary Kunkel; Zhaoping Zhang; Jian Min Deng; Richard R Behringer; Benoit de Crombrugghe
Journal:  Cell       Date:  2002-01-11       Impact factor: 41.582

Review 8.  Mechanisms balancing skeletal matrix synthesis and degradation.

Authors:  Harry C Blair; Mone Zaidi; Paul H Schlesinger
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

9.  Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.

Authors:  Romain Dacquin; Michael Starbuck; Thorsten Schinke; Gérard Karsenty
Journal:  Dev Dyn       Date:  2002-06       Impact factor: 3.780

Review 10.  Runx2, a multifunctional transcription factor in skeletal development.

Authors:  Toshihisa Komori
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

View more
  32 in total

1.  p53 inhibits SP7/Osterix activity in the transcriptional program of osteoblast differentiation.

Authors:  Natalia Artigas; Beatriz Gámez; Mónica Cubillos-Rojas; Cristina Sánchez-de Diego; José Antonio Valer; Gabriel Pons; José Luis Rosa; Francesc Ventura
Journal:  Cell Death Differ       Date:  2017-08-04       Impact factor: 15.828

2.  The transcriptional activity of osterix requires the recruitment of Sp1 to the osteocalcin proximal promoter.

Authors:  Corinne Niger; Florence Lima; David J Yoo; Rishi R Gupta; Atum M Buo; Carla Hebert; Joseph P Stains
Journal:  Bone       Date:  2011-07-28       Impact factor: 4.398

3.  Mitogen-activated protein kinase (MAPK)-regulated interactions between Osterix and Runx2 are critical for the transcriptional osteogenic program.

Authors:  Natalia Artigas; Carlos Ureña; Edgardo Rodríguez-Carballo; José Luis Rosa; Francesc Ventura
Journal:  J Biol Chem       Date:  2014-08-13       Impact factor: 5.157

4.  Osterix and NO66 histone demethylase control the chromatin of Osterix target genes during osteoblast differentiation.

Authors:  Krishna M Sinha; Hideyo Yasuda; Xin Zhou; Benoit deCrombrugghe
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

5.  p38 regulates expression of osteoblast-specific genes by phosphorylation of osterix.

Authors:  María José Ortuño; Silvia Ruiz-Gaspà; Edgardo Rodríguez-Carballo; Antonio R G Susperregui; Ramon Bartrons; José Luis Rosa; Francesc Ventura
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

6.  Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta.

Authors:  Pablo Lapunzina; Mona Aglan; Samia Temtamy; José A Caparrós-Martín; Maria Valencia; Rocío Letón; Victor Martínez-Glez; Rasha Elhossini; Khalda Amr; Nuria Vilaboa; Victor L Ruiz-Perez
Journal:  Am J Hum Genet       Date:  2010-06-24       Impact factor: 11.025

7.  Regulation of Bone Metabolism.

Authors:  Maryam Shahi; Amir Peymani; Mehdi Sahmani
Journal:  Rep Biochem Mol Biol       Date:  2017-04

Review 8.  Genetic and molecular control of osterix in skeletal formation.

Authors:  Krishna M Sinha; Xin Zhou
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

9.  Osterix is required for cranial neural crest-derived craniofacial bone formation.

Authors:  Wook-Young Baek; Young-Ji Kim; Benoit de Crombrugghe; Jung-Eun Kim
Journal:  Biochem Biophys Res Commun       Date:  2013-01-09       Impact factor: 3.575

10.  Osterix/Sp7 limits cranial bone initiation sites and is required for formation of sutures.

Authors:  Erika Kague; Paula Roy; Garrett Asselin; Gui Hu; Jacqueline Simonet; Alexandra Stanley; Craig Albertson; Shannon Fisher
Journal:  Dev Biol       Date:  2016-03-16       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.